Literature DB >> 33837995

Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Sudan.

Tomader Ali Mohammed Ibrahim1, Denira Govender2,3, Mohamed Ahmed Abdullah1,4, Janelle Annette Noble5,6, Mohammed Osman Hussien7, Julie Ann Lane5, Steven John Mack6, Gregory George Noble Martin5, Mark Alvin Atkinson8,9, Clive Henry Wasserfall8, Graham David Ogle2,3.   

Abstract

OBJECTIVE: To further understand clinical and biochemical features, and HLA-DRB1 genotypes, in new cases of diabetes in Sudanese children and adolescents. RESEARCH DESIGN AND METHODS: Demographic characteristics, clinical information, and biochemical parameters (blood glucose, HbA1c, C-peptide, autoantibodies against glutamic acid decarboxylase 65 [GADA] and insulinoma-associated protein-2 [IA-2A], and HLA-DRB1) were assessed in 99 individuals <18 years, recently (<18 months) clinically diagnosed with T1D. HLA-DRB1 genotypes for 56 of these Arab individuals with T1D were compared to a mixed control group of 198 healthy Arab (75%) and African (25%) individuals without T1D.
RESULTS: Mean ± SD age at diagnosis was 10.1 ± 4.3 years (range 0.7-17.6 years) with mode at 9-12 years. A female preponderance was observed. Fifty-two individuals (55.3%) presented in diabetic ketoacidosis (DKA). Mean ± SD serum fasting C-peptide values were 0.22 ± 0.25 nmol/L (0.66±0.74 ng/ml). 31.3% were autoantibody negative, 53.4% were GADA positive, 27.2% were IA-2A positive, with 12.1% positive for both autoantibodies. Association analysis compared to 198 controls of similar ethnic origin revealed strong locus association with HLA-DRB1 (p < 2.4 × 10-14 ). Five HLA-DRB1 alleles exhibited significant T1D association: three alleles (DRB1*03:01, DRB1*04:02, and DRB1*04:05) were positively associated, while three (DRB1*10:01, DRB1*15:02, and DRB1*15:03) were protective. DRB1*03:01 had the strongest association (odds ratio = 5.04, p = 1.7 × 10-10 ).
CONCLUSIONS: Young Sudanese individuals with T1D generally have similar characteristics to reported European-origin T1D populations. However, they have higher rates of DKA and slightly lower autoantibody rates than reported European-origin populations, and a particularly strong association with HLA-DRB1*03:01.
© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-peptide; HLA; Sudan; autoantibodies; childhood diabetes

Mesh:

Substances:

Year:  2021        PMID: 33837995      PMCID: PMC8274711          DOI: 10.1111/pedi.13209

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   3.409


  34 in total

1.  Hardy-Weinberg testing for HLA class II (DRB1, DQA1, DQB1, and DPB1) loci in 26 human ethnic groups.

Authors:  J J Chen; J A Hollenbach; E A Trachtenberg; J J Just; M Carrington; K S Rønningen; A Begovich; M C King; S McWeeney; S J Mack; H A Erlich; G Thomson
Journal:  Tissue Antigens       Date:  1999-12

2.  The variance for the disequilibrium coefficient in the individual Hardy-Weinberg test.

Authors:  J J Chen; G Thomson
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

3.  Performing the exact test of Hardy-Weinberg proportion for multiple alleles.

Authors:  S W Guo; E A Thompson
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

4.  WHO Child Growth Standards based on length/height, weight and age.

Authors: 
Journal:  Acta Paediatr Suppl       Date:  2006-04

Review 5.  Role of humoral beta-cell autoimmunity in type 1 diabetes.

Authors:  Mikael Knip; Heli Siljander; Jorma Ilonen; Olli Simell; Riitta Veijola
Journal:  Pediatr Diabetes       Date:  2016-07       Impact factor: 4.866

6.  Analysis of HLA-DR and -DQ gene polymorphisms in Sudanese patients with type 1 (insulin-dependent) diabetes.

Authors:  M M Magzoub; H A Stephens; E A Gale; G F Bottazzo
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Authors:  Manuela Battaglia; Simi Ahmed; Mark S Anderson; Mark A Atkinson; Dorothy Becker; Polly J Bingley; Emanuele Bosi; Todd M Brusko; Linda A DiMeglio; Carmella Evans-Molina; Stephen E Gitelman; Carla J Greenbaum; Peter A Gottlieb; Kevan C Herold; Martin J Hessner; Mikael Knip; Laura Jacobsen; Jeffrey P Krischer; S Alice Long; Markus Lundgren; Eoin F McKinney; Noel G Morgan; Richard A Oram; Tomi Pastinen; Michael C Peters; Alessandra Petrelli; Xiaoning Qian; Maria J Redondo; Bart O Roep; Desmond Schatz; David Skibinski; Mark Peakman
Journal:  Diabetes Care       Date:  2019-11-21       Impact factor: 19.112

8.  Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.

Authors:  Jorma Ilonen; Johanna Lempainen; Anna Hammais; Antti-Pekka Laine; Taina Härkönen; Jorma Toppari; Riitta Veijola; Mikael Knip
Journal:  Pediatr Diabetes       Date:  2017-06-09       Impact factor: 4.866

9.  Diabetic ketoacidosis in children in Khartoum city, Sudan.

Authors:  A Elamin; K M Kheir; T Tuvemo
Journal:  East Afr Med J       Date:  1994-02

10.  Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline.

Authors:  Jill A Hollenbach; Steven J Mack; Derek J Pappas; Wesley Marin
Journal:  Hum Immunol       Date:  2015-12-18       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.